CH Biotech R&D Co., Ltd. (6534.TW)

TWD 80.6

(-0.49%)

EBITDA Summary of CH Biotech R&D Co., Ltd.

  • CH Biotech R&D Co., Ltd.'s latest annual EBITDA in 2023 was 761.55 Million TWD , up 5.37% from previous year.
  • CH Biotech R&D Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was 208.69 Million TWD , down -63.24% from previous quarter.
  • CH Biotech R&D Co., Ltd. reported an annual EBITDA of 722.29 Million TWD in 2022, up 53.53% from previous year.
  • CH Biotech R&D Co., Ltd. reported an annual EBITDA of 470.2 Million TWD in 2021, up 89.33% from previous year.
  • CH Biotech R&D Co., Ltd. reported a quarterly EBITDA of 572.33 Million TWD for 2024 Q1, up 2042.75% from previous quarter.
  • CH Biotech R&D Co., Ltd. reported a quarterly EBITDA of -30.22 Million TWD for 2023 Q4, down -151.26% from previous quarter.

Annual EBITDA Chart of CH Biotech R&D Co., Ltd. (2023 - 2019)

Historical Annual EBITDA of CH Biotech R&D Co., Ltd. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 761.55 Million TWD 5.37%
2022 722.29 Million TWD 53.53%
2021 470.2 Million TWD 89.33%
2020 248.32 Million TWD -29.47%
2019 352.05 Million TWD 0.0%

Peer EBITDA Comparison of CH Biotech R&D Co., Ltd.

Name EBITDA EBITDA Difference
Sinon Corporation 2.07 Billion TWD 63.35%
Taiwan Fertilizer Co., Ltd. 3.87 Billion TWD 80.369%
All Cosmos Bio-Tech Holding Corporation 305.41 Million TWD -149.351%